EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Credit Rating Analysis
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ マルマン
@ Mitsuchi
@ NIPPON ICHI SOFTWARE
@ 3-D Matrix
@ Kurogane Kosakusho
@ FUJICOPIAN
@ YA-MAN
@ THE SAILOR PEN
@ YAMATO 
@ NIX
@ MICS化学
@ chuo kagaku co.
@ EMCOM HOLDINGS
@ Medrx
@ UMN Pharma
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
NITCHITSU 
graph
KIKUSUI ELECTRONICS etc.
graph
KIKUSUI ELECTRONICS etc.
graph
日本アビオニクス
graph
日本アビオニクス
graph

Credit Rating Analysis: chuo kagaku co. (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

Credit Rating (Bankruptcy Risk): chuo kagaku co. (Annual ) Consolidated | Non-Consolidated

Date Credit Rating Comment Sales Current Profit Net Income
2012-12-31  B  Credit is not enough, easily undermined by biz environs. ¥ 59 B
-4.90%
¥ 618 M
-73.37%
¥ -741 M
-143.95%

Financial Timeline

Date  2012-12-31 
(Annual )
 2013-03-31 
(First quarter )
 2013-06-30 
(Second quarter )
 2013-09-30 
(Third quarter )
Credit Rating BCCCCCCC
Total Assets
¥ 48 B
¥ 47 B
¥ 46 B
¥ 46 B
Net Assets
¥ 14 B
¥ 14 B
¥ 13 B
¥ 12 B

Financial Statement Risk Analysis: chuo kagaku co. (Annual ) (Consolidated )

Special note
Net sales has dropped 4 consecutive terms. The business have high risk.
[Date: 2012-12-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -741 M) is minus or 0, so , there is a possibility that the management situation is severe.
Management Risk (*Sales is decrease )
Sales (¥ 59 B) is first term Sales (¥ 62 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Income is decrease )
Net Income (¥ -741 M) is first term Net Income (¥ 1 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-1.25%) is first term Net Profit Margin (2.70%) less , there is a possibility that the profitability has deteriorated.
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -1 B) & Financial Cash Flow (¥ -3 B) is a minus, Operating Cash Flow (¥ 1 B) is a plus,
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ -529 M) is Sales first term ratio (¥ -3 B) more , there is a possibility that the non-performing asset was increased.
[Date: 2011-12-31]  Danger : Warning : Caution : Good
Management Risk (*Sales is decrease )
Sales (¥ 62 B) is first term Sales (¥ 64 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Income is decrease )
Net Income (¥ 1 B) is first term Net Income (¥ 1 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (2.70%) is first term Net Profit Margin (3.03%) less , there is a possibility that the profitability has deteriorated.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 884 M) is Sales first term ratio (¥ -2 B) more , there is a possibility that the non-performing asset was increased.
[Date: 2010-12-31]  Danger : Warning : Caution : Good
Stated Capital less
Stated Capital (¥ 6 B) is first term Stated Capital (¥ 6 B) less , there is a possibility that the management situation is very severe.
Management Risk (*Sales is decrease )
Sales (¥ 64 B) is first term Sales (¥ 75 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Gross Income is decrease )
Gross Income (¥ 49 B) is first term Gross Income (¥ 56 B) less , there is a possibility that the management situation has stagnated and deteriorated
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -1 B) & Financial Cash Flow (¥ -2 B) is a minus, Operating Cash Flow (¥ 2 B) is a plus,
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 468 M) is Sales first term ratio (¥ -10 B) more , there is a possibility that the non-performing asset was increased.
[Date: 2009-12-31]  Danger : Warning : Caution : Good
Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -2 B) is a minus, Issuance of new shares (¥ 1 B) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -2 B) is minus or 0, so , there is a possibility that the management situation is severe.
Financing Risk (*Issuance of new shares)
Investment Cash Flow (¥ 801 M) is a plus, Issuance of new shares (¥ 1 B) is plus. Because it is thought that the circulating fund is gained by sale and new issue of stocks of stock property , there is a possibility that the financing is severe.

Ticker Market Industry Month report Rating
@ chuo kagaku co. 7895 OSE JASDAQ Other Products 3 Annual B

Related Company

@ EMCOM HOLDINGS (Sales ¥ 2 B)
@ YAMATO  (Sales ¥ 124 M)
@ chuo kagaku co. (Sales ¥ 59 B)
@ UMN Pharma (Sales ¥ 108 M)
@ THE SAILOR PEN (Sales ¥ 6 B)
@ Medrx (Sales ¥ 87 M)
@ YA-MAN (Sales ¥ 19 B)
@ 3-D Matrix (Sales ¥ 32 M)
@ NIPPON ICHI SOFTWARE (Sales ¥ 2 B)
@ EIDAI KAKO (Sales ¥ 5 B)
@ MICS化学 (Sales ¥ 2 B)
@ Mitsuchi (Sales ¥ 12 B)
@ NIX (Sales ¥ 3 B)
Sponsored Link


関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.075 sec.)